Chenhao Zhou
8PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 27, 2025
DysUFMylation of SREBP1 Promotes the Progression of Hepatocellular Carcinoma by Reprogramming Lipid Metabolism.Xukang Gao, Zeping Han, Min Xu
|Mar 14, 2024
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy.Jialei Weng, Zheng Wang, Zhiqiu Hu
|Feb 17, 2024
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.Wenxin Xu, Jialei Weng, Minghao Xu
|Jun 29, 2023
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma.Jialei Weng, Shaoqing Liu, Qiang Zhou
|Oct 28, 2022
A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma.Chenhao Zhou, Jialei Weng, Yuan Gao
|Jan 27, 2022
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients.Manar Atyah, Chenhao Zhou, Qiang Zhou
Pageof 2
